LSL Pharma Group Inc. (TSXV:LSL)
Canada · Delayed Price · Currency is CAD 0.3900
-0.0150 (-3.70%)
At close: Nov 27, 2025
LSL Pharma Group Market Cap
LSL Pharma Group has a market cap or net worth of CAD 47.28 million as of December 1, 2025. Its market cap has decreased by -13.85% in one year.
Market Cap
47.28M
Enterprise Value
68.88M
Revenue
26.80M
Ranking
n/a
PE Ratio
17.19
Stock Price
0.39
Market Cap Chart
Since March 2, 2023, LSL Pharma Group's market cap has decreased from 61.67M to 47.28M, a decrease of -23.34%. That is a compound annual growth rate of -9.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 27, 2025 | 47.28M | -0.20% |
| Dec 31, 2024 | 47.37M | 18.48% |
| Dec 29, 2023 | 39.98M | -35.17% |
| Mar 2, 2023 | 61.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.50B |
| dentalcorp Holdings | 2.18B |
| Sienna Senior Living | 1.95B |
| Green Thumb Industries | 1.93B |
| Extendicare | 1.72B |
| Cronos Group | 1.31B |
| Trulieve Cannabis | 1.27B |
| WELL Health Technologies | 977.45M |